News About: Pharm. Industry
Il Dong celebrated the 63th anniversary of company inauguration.
Il Dong Pharmaceutical Co. (CEO: Lee Kum-ki) took the 63 anniversary ceremony of the company inauguration at the company auditorium on May 4, thereby ensuring this year's target to fulfil for leaping up to be of the s...
EC approves Velcade for multiple myeloma treatment
The European Commission issued on April 27 a positive decision for Velcade (bortezomib) injection, a new treatment for multiple myeloma, a form of blood cancer.
A single license has been granted to market Velcade ...
Domestic pharmaceutical firms mull product restructuring
A number of domestic pharmaceutical firms are gearing up to concentrate their efforts on profit-making items via intensive product restructuring program designed to eliminate some items with little marketability, lowe...
Korea develops artificial bone for clinical trials
The artificial bone, developed by Daewoon Pharm and Bioalpha Co. for the first time in Korea, has obtained official approval from the Korea Food and Drug Administration for clinical trials.
This trials for 126 pati...
Bayer, GSK to start multinational comparative trials between Levitra and CialisBayer Korea and GSK said they are pressing ahead with multinational comparative trials to examine the therapeutic efficacy of both Levitra (vardenafil HCl) and Cialis (tadalafil...
|
Use of copy product hurts Korea's drug image
Instead of generic drugs, the frequent use of copy products at some quarters may give a negative impact to the quality of locally-manufactured products and image of domestic pharmaceutical industry, and thus all parti...
Hami's Oraxol, novel oral formulation of paclitaxel, inhibits neointimal hyperplasia in rat model
Hanmi Pharm said recently that Oraxol, oral formulations of paclitaxol, provide an effective means of inhibiting proliferative response to vascular injury in rat treated at a lower dose (5mg/kg), according to the rece...
Handok-Aventis to support 31 hospitals for free osteoporosis tests.
Handok-Aventis (President: Kim Young-jin) announced to put a nationwide event under the theme of "Osteoporosis test campaign for mothers and daughters together" through 31 general hospitals across the nation during Ma...
Enbrel to be launched in Korea
Wyeth Korea said it plans to launch Enbrel (etanercept) for the treatment of rheumatoid arthritis (RA) from May 29, as the third country in Asia following Australia and Taiwan.
Enbrel is the only biologic therapy a...
Insecticide makers focus on double market sectors in 2004
Korea's major insecticide makers plan to increase their market share this year to bolster profitability through banner advertisements targeting both pharmacy and discount stores, which will greatly affect sales of who...
